Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study

This publication has 30 references indexed in Scilit:

• The Prevention or Delay of Type 2 Diabetes
  Diabetes Care, 2002
• Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes?
  European Heart Journal, 2001
• Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
  Diabetes Care, 2000
• Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus
  Journal of the American College of Cardiology, 2000
• Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: A serial intravascular ultrasound study
  Journal of the American College of Cardiology, 2000
• Effect of statin therapy on restenosis after coronary stent implantation
  The American Journal of Cardiology, 2000
• PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle Cells
  Journal of Cardiovascular Pharmacology, 1999
• Pioglitazone Reduces Smooth Muscle Cell Density of Rat Carotid Arterial Intima Induced by Balloon Catheterization
  Hormone and Metabolic Research, 1997
• Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
  Journal of Clinical Investigation, 1996
• Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction
  Atherosclerosis, 1988